Genitourinary Syndrome of Menopause in Cancer Survivors.

Dugan, Catherine L; Othieno, Alisha A; Goldman, Mindy E

Dugan, Catherine L; Othieno, Alisha A; Goldman, Mindy E.

Afiliación

Dugan CL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
Othieno AA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
Goldman ME; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.

Clin Obstet Gynecol ; 67(1): 89-100, 2024 03 01.

Article en En | MEDLINE | ID: mdl-38108399

ABSTRACT

ABSTRACT

Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the safety of hormonal therapies, is important to understand. In this review, we cover important considerations in the assessment of GSM; nonpharmacologic, behavioral, integrative, pharmacologic, and medical device treatments for GSM the unique considerations in GSM by cancer treatment modality; bladder manifestations of GSM; and GSM in specific populations.

Asunto(s)

Supervivientes de Cáncer; Neoplasias; Femenino; Humanos; Neoplasias/patología; Menopausia; Vagina/patología; Estrógenos/uso terapéutico; Síndrome; Atrofia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Supervivientes de Cáncer / Neoplasias Límite: Female / Humans Idioma: En Revista: Clin Obstet Gynecol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google